United States · FDA National Drug Code directory
Chloraspetic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67172-023_23b269a2-35bd-4b89-88ea-a6305694e197
- Product NDC
- 67172-023
- Form
- LOZENGE
- Composition / generic term
- menthol and benzocaine
- Labeler
- Prestige Brands Holdings, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20100801
- Source listing expiry
- 20261231
Source-listed ingredients
- MENTHOL — 10 mg/1
- BENZOCAINE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (67172-023-18) / 6 LOZENGE in 1 BLISTER PACK · 67172-023-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →